HCP
The computed 12-month bankruptcy probability of HCP is 0.2% (very low). The 2024 annual accounts show equity of €2.26M and a net result of €101k. Equity is growing by ~30.3% per year across the filed fiscal years. Its solvency ranks better than 90% of 4927 sector peers (fiscal year 2024). The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €2.26M |
| Net result | €101k |
| Better than sector | 90% |
| Active | 20 yrs |
Strong profile, led by stability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 80.3% | 16.7% | |
| Net result | €101k | €2k | |
| Equity | €2.26M | €27k | |
| Gross operating margin | €41k | €27k | |
| Total assets | €2.82M | €302k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €35k |
| Net profit | €101k |
| Cash flow | €163k |
| Staff costs | - |
| Income taxes | €11k |
| Dividends | €464k |
| Total assets | €2.82M |
| Equity | €2.26M |
| Debt | €555k |
| of which ≤ 1y | €432k |
| of which > 1y | €123k |
| Working capital | €-102k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.76 |
| Quick ratio | 0.76 |
| Working capital ratio | -3.6% |
| Solvency | 80.3% |
| Debt / equity | 0.25 |
| Long-term debt ratio | 0.05 |
| Interest coverage | 4.22 |
| Gross margin | - |
| Net margin | - |
| ROA | 3.6% |
| ROE | 4.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.82M |
| Fixed assets | 21/28 | €2.49M |
| Tangible fixed assets | 22/27 | €391k |
| Financial fixed assets | 28 | €2.09M |
| Current assets | 29/58 | €330k |
| Amounts receivable within one year | 40/41 | €140k |
| Cash & bank | 54/58 | €185k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.82M |
| Equity | 10/15 | €2.26M |
| Contributions / capital | 10/11 | €12k |
| Reserves | 13 | €2.25M |
| Amounts payable | 17/49 | €555k |
| Amounts payable after one year | 17 | €123k |
| Amounts payable within one year | 42/48 | €432k |
| Trade debts payable within one year | 44 | €6k |
| Income statement | ||
| Gross operating margin | 9900 | €41k |
| Operating result | 9901 | €-27k |
| Financial income | 75 | €147k |
| Financial charges | 65 | €8k |
| Result before taxes | 9903 | €112k |
| Income taxes | 67/77 | €11k |
| Net result for the period | 9904 | €101k |
| Result to be appropriated | 9905 | €101k |
| NACE primary | Real estate activities(68110) |
| Legal form | Private limited company(610) |
| Incorporation | 26-06-2006 |
| Status | Active |
| Postal code | 9931 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 43011B0718/00F000 | Flanders | 8,031 m² | 1 · 173 m² | 6.8 m |
| 44053K0054/00D000 | Flanders | 2,689 m² | 1 · 60 m² | 4.1 m |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
31-01-2024 Discharge granted to the board
Technical details
{
"events": [
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HUYGHELIER Karl",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": true,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_pending",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "HUYGHELIER Karl",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "niet_statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "De algemene vergadering zal op de volgende jaarvergadering beslissen over de kwijting aan de ontslagnemende zaakvoerder voor de uitoefening van zijn mandaat.",
"decharge_status": "pending_next_agm",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "correction",
"role": null,
"person": null,
"reason": null,
"subkind": "rectification",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Niels Debakker",
"firm_city": null,
"firm_name": null,
"office_city": "Anzegem",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-31",
"filing_date": "2024-01-29",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-01-24",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2024-01-24",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2024-01-24",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2024-01-24",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2024-01-24",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2024-01-24",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0882.214.010",
"name_full": "HCP",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Niels Debakker",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van akte",
"geco\u00F6rdineerde statuten"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | HCP |